Orr Inbar, CEO, QuantHealth

Bio:- In this episode of Practical AI in Healthcare, we speak with Orr Inbar, CEO of QuantHealth, one of the leading companies pioneering AI-driven clinical trial simulation. Orr explains how QuantHealth integrates mechanistic biology, real-world data from hundreds of millions of patients, and advanced AI foundation models to simulate clinical trials with unusually high accuracy. The discussion explores why protocol design remains one of the most consequential — and error-prone — steps in drug development, and how simulation is helping pharma teams optimize eligibility criteria, endpoints, dosing strategies, safety considerations, and commercial positioning well before running a costly study. Together, we examine where simulation fits today, how companies are using it to rescue struggling trials, and what the next 3–10 years may look like as AI-first trial design becomes standard across R&D. A must-listen for anyone working in clinical development, R&D leadership, or life-science AI.